Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Weiss, R. D. Articles by Hennen, J. A. Search for Related Content PubMed Citation Articles by Weiss, R. D. Articles by Hennen, J. A. Other Addictive Disorders Psychodynamic Therapy Related Article

A Randomized Trial of Integrated Group Therapy Versus Group Drug Counseling for Patients With Bipolar Disorder and Substance Dependence

OBJECTIVE: Although bipolar disorder and substance use disorder frequently co-occur, there is little information on the effectiveness of behavioral treatment for this population. Integrated group therapy, which addresses the two disorders simultaneously, was compared with group drug counseling, which focuses on substance use. The authors hypothesized that patients receiving integrated group therapy would have fewer days of substance use and fewer weeks ill with bipolar disorder. METHOD: A randomized controlled trial compared 20 weeks of integrated group therapy or group drug counseling with 3 months of posttreatment follow-up. Sixty-two patients with bipolar disorder and current substance dependence, treated with mood stabilizers for 2 weeks, were randomly assigned to integrated group therapy (N=31) or group drug counseling (N=31). The primary outcome measure was the number of days of substance use. The primary mood outcome was the number of weeks ill with a mood episode. RESULTS: Intention-to-treat analysis revealed significantly fewer days of substance use for integrated group therapy patients during treatment and follow-up. Groups were similar in the number of weeks ill with bipolar disorder during treatment and follow-up, although integrated group therapy patients had more depressive and manic symptoms. CONCLUSIONS: Integrated group therapy, a new treatment developed specifically for patients with bipolar disorder and substance dependence, appears to be a promising approach to reduce substance use in this population.

Related Article:

In This Issue
Am J Psychiatry 2007 164: A52. [Full Text] [PDF]

This article has been cited by other articles:

				G. Goodwin and Consensus Group of the British Association for Psy Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology J Psychopharmacol, June 1, 2009; 23(4): 346 - 388. [Abstract] [PDF]

				L. A. Copeland, A. L. Miller, D. E. Welsh, J. F. McCarthy, J. E. Zeber, and A. M. Kilbourne Clinical and Demographic Factors Associated With Homelessness and Incarceration Among VA Patients With Bipolar Disorder Am J Public Health, May 1, 2009; 99(5): 871 - 877. [Abstract] [Full Text] [PDF]

				D. J. Miklowitz Adjunctive Psychotherapy for Bipolar Disorder: State of the Evidence Am J Psychiatry, November 1, 2008; 165(11): 1408 - 1419. [Abstract] [Full Text] [PDF]

				B. A. Gaudiano, L. M. Weinstock, and I. W. Miller Improving Treatment Adherence in Bipolar Disorder: A Review of Current Psychosocial Treatment Efficacy and Recommendations for Future Treatment Development Behav Modif, May 1, 2008; 32(3): 267 - 301. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us